GR3003749T3 - - Google Patents

Info

Publication number
GR3003749T3
GR3003749T3 GR910401848T GR910401848T GR3003749T3 GR 3003749 T3 GR3003749 T3 GR 3003749T3 GR 910401848 T GR910401848 T GR 910401848T GR 910401848 T GR910401848 T GR 910401848T GR 3003749 T3 GR3003749 T3 GR 3003749T3
Authority
GR
Greece
Prior art keywords
pgfs
blood pressure
vassopressors
ephemeral
trachea
Prior art date
Application number
GR910401848T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3003749T3 publication Critical patent/GR3003749T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
GR910401848T 1987-04-30 1992-02-10 GR3003749T3 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10752987 1987-04-30
JP23589087 1987-09-18

Publications (1)

Publication Number Publication Date
GR3003749T3 true GR3003749T3 (enExample) 1993-03-16

Family

ID=26447552

Family Applications (1)

Application Number Title Priority Date Filing Date
GR910401848T GR3003749T3 (enExample) 1987-04-30 1992-02-10

Country Status (11)

Country Link
US (1) US5106869A (enExample)
EP (1) EP0289349B1 (enExample)
JP (1) JPH0667900B2 (enExample)
KR (1) KR930006202B1 (enExample)
AT (1) ATE72235T1 (enExample)
CA (1) CA1324129C (enExample)
DE (2) DE3868127D1 (enExample)
ES (1) ES2032016T3 (enExample)
GR (1) GR3003749T3 (enExample)
NL (1) NL300135I2 (enExample)
ZA (1) ZA886909B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209939B (en) * 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
DE68929435T2 (de) 1988-09-06 2003-07-17 Pharmacia Ab, Stockholm Prostaglandinderivate zur Behandlung des grünen Stars oder einer okularen Hypertension
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
DE69019431T2 (de) * 1989-07-27 1995-09-14 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von 15-Keto-Prostansäure-Derivaten zur Herstellung eines Medikaments für die Verbesserung der Ausscheidung des Kaliumions.
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
CA2022372C (en) * 1989-08-09 2000-05-02 Ryuji Ueno Improvement of excretion of nonprotein nitrogen into the intestine by prostanoic acid derivatives
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
TW249226B (enExample) * 1990-04-04 1995-06-11 Aderk Ueno Kk
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ATE141794T1 (de) * 1991-03-14 1996-09-15 R Tech Ueno Ltd Stimulierung von wundheilung mit 15-keto- prostaglandinverbindungen
CA2065889C (en) * 1991-10-02 2002-08-27 Tetsuya Sugiyama Increasing the choroidal blood flow
ES2105333T3 (es) * 1992-10-13 1997-10-16 Alcon Lab Inc Combinaciones de prostaglandinas y derivados de clonidina para el tratamiento del glaucoma.
US6294563B1 (en) 1994-10-27 2001-09-25 Allergan Sales, Inc. Combinations of prostaglandins and brimonidine or derivatives thereof
HU223345B1 (hu) 1995-12-20 2004-08-30 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Eljárás alfa, béta-telítetlen ketonok sztereoszelektív redukciójára
AU7680096A (en) * 1995-12-22 1997-07-17 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
US6770675B2 (en) 1997-03-17 2004-08-03 Novartis Ag Compositions and methods for reducing ocular hypertension
ID24845A (id) * 1997-09-09 2000-08-24 Procter & Gamble Prostaglandin tetrahidro tersubstitusi c16-c20 aromatik yang berguna sebagai agonis fp
TWI225398B (en) * 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
WO2001046134A1 (en) * 1999-12-22 2001-06-28 Alcon Universal Ltd. 6-KETO PROSTAGLANDIN F1α AND ANALOGS FOR TREATING DRY EYE
KR101160780B1 (ko) * 2002-08-29 2012-06-27 산텐 세이야꾸 가부시키가이샤 Ｒｈｏ 키나아제 억제제 및 프로스타글란딘류를 포함하는 녹내장 치료제
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
JP5222462B2 (ja) 2003-08-21 2013-06-26 スキャンポ・アーゲー 眼科用組成物
DE602004023106D1 (de) 2003-11-07 2009-10-22 Senju Pharma Co Pharmazeutische zusammensetzung mit prostaglandin
JP4892483B2 (ja) * 2004-12-29 2012-03-07 株式会社アールテック・ウエノ 頭皮および毛髪の処置のための組成物および方法
CN104983712A (zh) * 2006-01-24 2015-10-21 株式会社·R-技术上野 软明胶胶囊制剂
WO2007105691A1 (ja) 2006-03-13 2007-09-20 R-Tech Ueno, Ltd. 水性組成物
CN103561748A (zh) 2011-04-07 2014-02-05 苏坎波公司 治疗眼疲劳的方法
CA2842455A1 (en) 2011-08-05 2013-02-14 Sucampo Ag Method for treating schizophrenia
AR092821A1 (es) 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero
JP6162646B2 (ja) * 2014-05-27 2017-07-12 信越化学工業株式会社 ３，５−ジメチルドデカン酸の製造方法
US20170020890A1 (en) 2015-06-19 2017-01-26 Sucampo Ag Pharmaceutical composition comprising fatty acid derivative

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3505386A (en) * 1965-12-29 1970-04-07 Upjohn Co Compounds related to prostaglandins
US3984455A (en) 1973-07-16 1976-10-05 The Upjohn Company Prostaglandin E1 analogs
GB1476661A (en) * 1974-05-13 1977-06-16 American Cyanamid Co Prostaglandins
IL51189A (en) * 1976-02-04 1985-08-30 Upjohn Co Prostaglandin analogs
JPS60208917A (ja) * 1984-02-29 1985-10-21 ジ・アツプジヨン・カンパニー Ａｒｄｓおよび多器官不全治療、予防におけるプロスタグランジンの使用
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
FR2613722B1 (fr) * 1987-04-07 1990-11-23 Bp Chimie Sa Procede de fabrication de granules d'homopolymere ou de copolymere de propylene

Also Published As

Publication number Publication date
CA1324129C (en) 1993-11-09
NL300135I2 (nl) 2004-05-03
NL300135I1 (nl) 2003-12-01
KR880012540A (ko) 1988-11-28
US5106869A (en) 1992-04-21
JPH0667900B2 (ja) 1994-08-31
ATE72235T1 (de) 1992-02-15
KR930006202B1 (ko) 1993-07-08
ES2032016T3 (es) 1993-01-01
DE10399038I2 (de) 2004-09-23
DE3868127D1 (de) 1992-03-12
DE10399038I1 (de) 2004-05-06
JPH01151552A (ja) 1989-06-14
ZA886909B (en) 1989-05-30
EP0289349A1 (en) 1988-11-02
EP0289349B1 (en) 1992-01-29

Similar Documents

Publication Publication Date Title
ZA886909B (en) Prostaglandins of the f series
AU635358B2 (en) Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
DE3883551D1 (de) Druckausbalancierte Dichtung mit "S" Querschnitt.
MY106705A (en) Composites and methods for making same.
GR3018513T3 (en) Process for the preparation of peroxidic perfluoropolyethers.
EP0313061A3 (en) Improved process for the manufacture of 1,1,1-trifluorodichloroethane and 1,1,1,2-tetrafluorochloroethane
CA1251462C (enExample)
FI853255A7 (fi) Menetelmä 6-kloori-N-metyyli-2,3,4,5 -tetrahydro-1H-3-bentsatsepiinin valmistamiseksi.
IT8519908A0 (it) Procedimento per produrre difenilammine oppure n,n'-difenil-fenilendiammine.
IT8422916A0 (it) Procedimento per la produzione dicorpi carboniosi.
IT8820935A0 (it) Procedimento per la preparazione di 1,2,5,6,9,10 esabromociclododecano.
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
EP0340391A3 (en) 1,4-disubstituted-2,3,4,6-tetrahydroxy-1,4-diphosphorinane and their oxides or sulfides
IT1216560B (it) Procedimento per la preparazione di bis(2,2,6,6_tetrametil_4_piperidil)ammina.
GR3017358T3 (en) 5-Aryl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants.
IE810767L (en) Prepartion of 2, 2, 6, 6-tetramethylpiperidone-4.
AU3660284A (en) (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
GR3004866T3 (enExample)
GR3005231T3 (enExample)
FI851969A7 (fi) Korkean verenpaineen hoitoon soveltuvia tetrahydronaftalenoleja.
SU1216944A1 (ru) Способ получения 2,6-ди-трет-бутилфенола
IT8520633A0 (it) Procedimento per la preparazione della 1-(4,6-bis-allilammino-s-triazinil)-4-(p,p'-difluorobenzidril)piperazi na.
IE870825L (en) 1,4-diazepines.
IE873477L (en) Preparation of 1,1,2,2-tetrahydroperfluoroalkanols and their¹esters.
FI883823A7 (fi) Eteenin ja 1,3-butadieenin kopolymeerejä.